USAQ
QHSLab, Inc.
Price Chart
Latest Quote
$0.45
| Previous Close | $0.57 |
| Open | $0.50 |
| Day High | $0.50 |
| Day Low | $0.34 |
| Volume | 2,950 |
Stock Information
| Shares Outstanding | 15.03M |
| Total Debt | $130K |
| Cash Equivalents | $362K |
| Revenue | $2.78M |
| Net Income | $433K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $6.78M |
| P/E Ratio | 15.03 |
| EPS (TTM) | $0.03 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $6.54M |
| Sales | $2.78M |
| Income | $433K |
| Book/sh | $0.10 |
| Cash/sh | $0.02 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 1.53 |
| Current Ratio | 1.68 |
| Debt/Eq | 8.56 |
Returns & Margins
| ROA | 1.72% |
| ROE | 93.18% |
| Gross Margin | 66.73% |
| Operating Margin | -12.95% |
| Profit Margin | 15.61% |
Ownership
| Insider Ownership | 48.73% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.02 |
| P/S | 2.44 |
| P/B | 4.47 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.53 |
| SMA50 | $0.59 |
| SMA200 | $0.46 |
| RSI | 38.91 |
| ATR | 0.0475 |
| Shares Float | 6.37M |
| Volatility | 0.48 |
| Rel Volume | 0.51 |
Performance History
| Week | -2.80% |
| Month | -23.56% |
| Quarter | -26.07% |
| 6 Months | +25.28% |
| YTD | -49.89% |
| Year | +131.28% |
| 3 Years | +204.73% |
| 5 Years | -33.58% |
| 10 Years | +310.00% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $0.45 | 800 |
| 2026-06-02 | $0.57 | 0 |
| 2026-06-01 | $0.57 | 0 |
| 2026-05-29 | $0.57 | 3,700 |
| 2026-05-28 | $0.46 | 0 |
| 2026-05-27 | $0.46 | 0 |
| 2026-05-26 | $0.46 | 3,500 |
| 2026-05-22 | $0.52 | 0 |
| 2026-05-21 | $0.52 | 0 |
| 2026-05-20 | $0.52 | 0 |
| 2026-05-19 | $0.52 | 1,000 |
| 2026-05-18 | $0.45 | 0 |
| 2026-05-15 | $0.45 | 0 |
| 2026-05-14 | $0.45 | 10,100 |
| 2026-05-13 | $0.55 | 200 |
| 2026-05-12 | $0.55 | 1,000 |
| 2026-05-11 | $0.56 | 1,500 |
| 2026-05-08 | $0.66 | 2,500 |
| 2026-05-07 | $0.66 | 0 |
| 2026-05-06 | $0.66 | 7,000 |
| 2026-05-05 | $0.59 | 0 |
About QHSLab, Inc.
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health system lab expert system (QHSLab), designed to function as an extension of a medical practice's existing clinical workflow that supports structured screening, automated documentation, and digital follow-up while minimizing disruption to physicians and staff; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.
đ° Latest News
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $699,573 | $540,925 | $567,820 | $743,673 |
| Cost Of Revenue | $774,036 | $615,388 | $623,667 | $743,673 |
| Total Revenue | $2,131,926 | $1,408,995 | $1,243,186 | $1,414,421 |
| Operating Revenue | $2,131,926 | $1,408,995 | $1,243,186 | $1,414,421 |
| Expenses | ||||
| Interest Expense | $465,055 | $230,494 | $433,442 | $246,490 |
| Total Expenses | $1,926,188 | $1,649,153 | $1,803,725 | $1,916,679 |
| Other Income Expense | $78 | $2,290 | $-2,020 | $-21,428 |
| Other Non Operating Income Expenses | $78 | $2,290 | - | - |
| Net Non Operating Interest Income Expense | $-465,055 | $-230,494 | $-433,442 | $-246,490 |
| Interest Expense Non Operating | $465,055 | $230,494 | $433,442 | $246,490 |
| Operating Expense | $1,152,152 | $1,033,765 | $1,180,058 | $1,173,006 |
| Selling And Marketing Expense | $509,065 | $488,537 | $530,317 | $592,068 |
| General And Administrative Expense | $276,496 | $259,108 | $387,512 | $454,008 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Net Interest Income | $-465,055 | $-230,494 | $-433,442 | $-246,490 |
| Normalized Income | $-259,239 | $-468,362 | $-993,981 | $-748,748 |
| Net Income From Continuing And Discontinued Operation | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Total Operating Income As Reported | $205,738 | $-240,158 | $-560,539 | $-502,258 |
| Net Income Common Stockholders | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Net Income | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Net Income Including Noncontrolling Interests | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Net Income Continuous Operations | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Pretax Income | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Operating Income | $205,738 | $-240,158 | $-560,539 | $-502,258 |
| Depreciation Amortization Depletion Income Statement | $72,112 | $72,112 | $72,112 | $36,056 |
| Depreciation And Amortization In Income Statement | $72,112 | $72,112 | $72,112 | $36,056 |
| Amortization Of Intangibles Income Statement | $72,112 | $72,112 | $72,112 | $36,056 |
| Gross Profit | $1,357,890 | $793,607 | $619,519 | $670,748 |
| Special Income Charges | - | $0 | $-2,020 | $-21,428 |
| Per Share | ||||
| Diluted EPS | $-0.03 | $-0.05 | $-0.11 | $-0.10 |
| Basic EPS | $-0.03 | $-0.05 | $-0.11 | $-0.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $352,391 | $-91,293 | $-432,580 | $-466,202 |
| Reconciled Depreciation | $146,575 | $146,575 | $127,959 | $36,056 |
| EBITDA (Bullshit earnings) | $352,391 | $-91,293 | $-434,600 | $-487,630 |
| EBIT | $205,816 | $-237,868 | $-562,559 | $-523,686 |
| Diluted Average Shares | $10,288,458 | $9,416,768 | $8,997,129 | $7,861,077 |
| Basic Average Shares | $10,288,458 | $9,416,768 | $8,997,129 | $7,861,077 |
| Diluted NI Availto Com Stockholders | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Amortization | $72,112 | $72,112 | $72,112 | $36,056 |
| Research And Development | $294,479 | $214,008 | $190,117 | $90,874 |
| Selling General And Administration | $785,561 | $747,645 | $917,829 | $1,046,076 |
| Other Gand A | $276,496 | $259,108 | $387,512 | $454,008 |
| Total Unusual Items | - | $0 | $-2,020 | $-21,428 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-2,020 | $-21,428 |
| Other Special Charges | - | - | $2,020 | $21,428 |
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,986,481 | $-1,900,917 | $-1,595,630 | $-938,649 |
| Total Assets | $1,799,552 | $1,681,432 | $1,957,453 | $2,208,497 |
| Total Non Current Assets | $1,378,725 | $1,525,300 | $1,671,875 | $1,762,715 |
| Goodwill And Other Intangible Assets | $1,378,725 | $1,525,300 | $1,671,875 | $1,762,715 |
| Other Intangible Assets | $1,378,725 | $1,525,300 | $1,671,875 | $1,762,715 |
| Current Assets | $420,827 | $156,132 | $285,578 | $445,782 |
| Other Current Assets | $25,791 | $7,987 | $7,310 | $22,713 |
| Inventory | $41,779 | $25,181 | $51,840 | $65,740 |
| Receivables | $196,089 | $71,382 | $47,734 | $70,474 |
| Accounts Receivable | $196,089 | $71,382 | $47,734 | $70,474 |
| Allowance For Doubtful Accounts Receivable | $-22,724 | $-18,445 | $-8,230 | $0 |
| Gross Accounts Receivable | $218,813 | $89,827 | $55,964 | $70,474 |
| Cash Cash Equivalents And Short Term Investments | $157,168 | $51,582 | $178,694 | $286,855 |
| Cash And Cash Equivalents | $157,168 | $51,582 | $178,694 | $286,855 |
| Cash Financial | $157,168 | $51,582 | $178,694 | $286,855 |
| Prepaid Assets | - | - | - | $22,713 |
| Debt | ||||
| Net Debt | $1,565,233 | $1,729,970 | $1,499,997 | $1,012,070 |
| Total Debt | $1,722,401 | $1,781,552 | $1,678,691 | $1,298,925 |
| Current Debt And Capital Lease Obligation | $1,722,401 | $1,781,552 | $1,504,309 | $795,969 |
| Current Debt | $1,722,401 | $1,781,552 | $1,504,309 | $795,969 |
| Other Current Borrowings | $1,722,401 | $1,781,552 | $1,504,309 | $795,969 |
| Long Term Debt And Capital Lease Obligation | - | - | $174,382 | $502,956 |
| Long Term Debt | - | - | $174,382 | $502,956 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,407,308 | $2,057,049 | $1,881,208 | $1,384,431 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $174,382 | $509,477 |
| Current Liabilities | $2,407,308 | $2,057,049 | $1,706,826 | $874,954 |
| Other Current Liabilities | $343,945 | $196,590 | $116,774 | $58,615 |
| Payables And Accrued Expenses | $340,962 | $78,907 | $85,743 | $20,370 |
| Payables | $340,962 | $78,907 | $85,743 | - |
| Accounts Payable | $340,962 | $78,907 | $85,743 | - |
| Equity | ||||
| Common Stock Equity | $-608,128 | $-375,989 | $75,873 | $823,694 |
| Preferred Stock Equity | $372 | $372 | $372 | $372 |
| Total Equity Gross Minority Interest | $-607,756 | $-375,617 | $76,245 | $824,066 |
| Stockholders Equity | $-607,756 | $-375,617 | $76,245 | $824,066 |
| Retained Earnings | $-4,331,350 | $-3,983,258 | $-3,514,896 | $-2,518,895 |
| Other Equity Interest | - | - | - | $-6,968 |
| Other | ||||
| Ordinary Shares Number | $10,806,527 | $9,735,508 | $9,315,508 | $8,756,093 |
| Share Issued | $10,806,527 | $9,735,508 | $9,315,508 | $8,756,093 |
| Tangible Book Value | $-1,986,853 | $-1,901,289 | $-1,596,002 | $-939,021 |
| Invested Capital | $1,114,273 | $1,405,563 | $1,754,564 | $2,122,619 |
| Working Capital | $-1,986,481 | $-1,900,917 | $-1,421,248 | $-429,172 |
| Total Capitalization | $-607,756 | $-375,617 | $250,627 | $1,327,022 |
| Additional Paid In Capital | $3,722,141 | $3,606,295 | $3,589,837 | $3,348,681 |
| Capital Stock | $1,453 | $1,346 | $1,304 | $1,248 |
| Common Stock | $1,081 | $974 | $932 | $876 |
| Preferred Stock | $372 | $372 | $372 | $372 |
| Non Current Accrued Expenses | - | - | $0 | $6,521 |
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $142,437 | $-159,627 | $-388,113 | $-509,309 |
| Operating Activities | ||||
| Operating Cash Flow | $142,437 | $-159,627 | $-350,994 | $-354,738 |
| Cash Flow From Continuing Operating Activities | $142,437 | $-159,627 | $-350,994 | $-354,738 |
| Operating Gains Losses | - | - | $2,020 | $21,428 |
| Investing Activities | ||||
| Investing Cash Flow | - | $0 | $-37,119 | $-154,571 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-37,119 | $-154,571 |
| Capital Expenditure Reported | - | $0 | $-37,119 | $-154,571 |
| Capital Expenditure | - | - | $-37,119 | $-154,571 |
| Financing Activities | ||||
| Financing Cash Flow | $-36,851 | $32,515 | $279,952 | $701,822 |
| Cash Flow From Continuing Financing Activities | $-36,851 | $32,515 | $279,952 | $701,822 |
| Issuance Of Capital Stock | - | $0 | $50,000 | $30,000 |
| Net Common Stock Issuance | - | $0 | $50,000 | $30,000 |
| Common Stock Issuance | - | $0 | $50,000 | $30,000 |
| Net Other Financing Charges | - | - | $-30,000 | $-85,000 |
| Other | ||||
| Repayment Of Debt | $-193,651 | $-359,421 | $-379,848 | $-179,178 |
| Issuance Of Debt | $156,800 | $391,936 | $639,800 | $936,000 |
| Interest Paid Supplemental Data | $245,995 | $61,295 | $71,785 | $43,023 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $157,168 | $51,582 | $178,694 | $286,855 |
| Beginning Cash Position | $51,582 | $178,694 | $286,855 | $94,342 |
| Changes In Cash | $105,586 | $-127,112 | $-108,161 | $192,513 |
| Net Issuance Payments Of Debt | $-36,851 | $32,515 | $259,952 | $756,822 |
| Net Long Term Debt Issuance | $-36,851 | $32,515 | $259,952 | $756,822 |
| Long Term Debt Payments | $-193,651 | $-359,421 | $-379,848 | $-179,178 |
| Long Term Debt Issuance | $156,800 | $391,936 | $639,800 | $936,000 |
| Change In Working Capital | $235,723 | $61,862 | $163,750 | $-30,423 |
| Change In Other Current Liabilities | $137,055 | $76,580 | $54,563 | $30,237 |
| Change In Payables And Accrued Expense | $262,055 | $-6,836 | $65,374 | $-73,554 |
| Change In Payable | $262,055 | $-6,836 | $65,374 | $-125,052 |
| Change In Account Payable | $262,055 | $-6,836 | $65,374 | $-125,052 |
| Change In Prepaid Assets | $-17,804 | $-677 | $15,403 | $-11,115 |
| Change In Inventory | $-16,598 | $26,659 | $13,900 | $33,961 |
| Change In Receivables | $-128,985 | $-33,864 | $14,510 | $-9,952 |
| Changes In Account Receivables | $-128,985 | $-33,864 | $14,510 | $-9,952 |
| Other Non Cash Items | $15,100 | $84,082 | $312,964 | $352,694 |
| Stock Based Compensation | $0 | $6,000 | $30,084 | $35,683 |
| Provisionand Write Offof Assets | $4,278 | $10,216 | $8,230 | $0 |
| Depreciation Amortization Depletion | $146,575 | $146,575 | $127,959 | $36,056 |
| Depreciation And Amortization | $146,575 | $146,575 | $127,959 | $36,056 |
| Amortization Cash Flow | $146,575 | $146,575 | $127,959 | $36,056 |
| Amortization Of Intangibles | $146,575 | $146,575 | $127,959 | $36,056 |
| Net Income From Continuing Operations | $-259,239 | $-468,362 | $-996,001 | $-770,176 |
| Change In Accrued Expense | - | - | $59,255 | $51,498 |
| Change In Interest Payable | - | - | $59,255 | $51,498 |
| Net Intangibles Purchase And Sale | - | - | - | $-154,571 |
| Purchase Of Intangibles | - | - | - | $-154,571 |